Company Schrödinger, Inc.

Equities

SDGR

US80810D1037

Software

Real-time Estimate Cboe BZX 12:28:58 2024-04-25 pm EDT 5-day change 1st Jan Change
23.1 USD -3.93% Intraday chart for Schrödinger, Inc. -5.82% -35.97%

Business Summary

Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.

Number of employees: 867

Sales per Business

USD in Million2022Weight2023Weight Delta
Software
73.4 %
136 74.9 % 159 73.4 % +17.37%
Drug Discovery
26.6 %
45 25.1 % 58 26.6 % +26.81%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
74.8 %
124 68.3 % 162 74.8 % +31.08%
EMEA
13.4 %
-- 29 13.4 % -
APAC
11.3 %
-- 25 11.3 % -
Rest of World
0.5 %
14 7.7 % 1 0.5 % -92.79%

Managers

Managers TitleAgeSince
Founder - 20-12-31
Chief Executive Officer 59 01-12-31
Director of Finance/CFO 63 22-08-17
Chief Tech/Sci/R&D Officer 67 22-12-31
Chief Tech/Sci/R&D Officer 40 06-08-31
Chief Tech/Sci/R&D Officer 47 09-01-31
Investor Relations Contact - 20-10-31
Corporate Officer/Principal - 22-12-31
Comptroller/Controller/Auditor - -
Corporate Officer/Principal 56 18-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 22-05-16
Chairman 64 17-12-31
Director/Board Member 61 20-04-29
Director/Board Member 62 19-06-30
Director/Board Member 60 19-01-22
Founder 71 89-12-31
Chief Executive Officer 59 01-12-31
Director/Board Member 67 19-09-23
Director/Board Member 68 20-04-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,164,193 0 0 85.21 %
Stock B 1 63,146,419 61,618,661 ( 97.58 %) 0

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
13.10 %
8,269,864 13.10 % 223 M $
Bill & Melinda Gates Foundation Trust
11.06 %
6,981,664 11.06 % 189 M $
Vanguard Fiduciary Trust Co.
10.73 %
6,776,631 10.73 % 183 M $
Baillie Gifford & Co.
4.121 %
2,602,389 4.121 % 70 M $
ARK Investment Management LLC
3.988 %
2,517,985 3.988 % 68 M $
2,192,972 3.473 % 59 M $
2,055,344 3.255 % 55 M $
Credit Suisse International
2.863 %
1,808,033 2.863 % 49 M $
Eaton Vance Management
2.819 %
1,780,197 2.819 % 48 M $
Nikko Asset Management Americas, Inc.
2.152 %
1,359,122 2.152 % 37 M $
NameEquities%Valuation
Bill & Melinda Gates Foundation Trust (Investment Management)
69.61 %
9,164,193 69.61 % 247 M $

Company contact information

Schrödinger, Inc.

1540 Broadway 24th floor

10036-4041, New York

+

http://www.schrodinger.com
address Schrödinger, Inc.(SDGR)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
24.04 USD
Average target price
37.7 USD
Spread / Average Target
+56.82%
Consensus
  1. Stock Market
  2. Equities
  3. SDGR Stock
  4. Company Schrödinger, Inc.